Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Hematopoietic stem cell development in the placenta.

Gekas C, Rhodes KE, Van Handel B, Chhabra A, Ueno M, Mikkola HK.

Int J Dev Biol. 2010;54(6-7):1089-98. doi: 10.1387/ijdb.103070cg. Review.

2.

The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report.

Rhodes KE, Simons JW, Soule HR.

Prostate. 2010 Jun 1;70(8):916-20. doi: 10.1002/pros.21127.

PMID:
20166134
3.

Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.

Gekas C, Rhodes KE, Gereige LM, Helgadottir H, Ferrari R, Kurdistani SK, Montecino-Rodriguez E, Bassel-Duby R, Olson E, Krivtsov AV, Armstrong S, Orkin SH, Pellegrini M, Mikkola HK.

Blood. 2009 Apr 9;113(15):3461-71. doi: 10.1182/blood-2008-07-167577. Epub 2009 Feb 11.

4.

Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.

Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ.

Clin Cancer Res. 2008 Nov 15;14(22):7554-63. doi: 10.1158/1078-0432.CCR-08-0351.

5.

Isolation and visualization of mouse placental hematopoietic stem cells.

Gekas C, Rhodes KE, Mikkola HK.

Curr Protoc Stem Cell Biol. 2008 Aug;Chapter 2:Unit 2A.8.1-2A.8.14. doi: 10.1002/9780470151808.sc02a08s6.

PMID:
18729047
6.

Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages.

Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, MacLellan WR.

Stem Cells. 2008 Jun;26(6):1537-46. doi: 10.1634/stemcells.2008-0033. Epub 2008 May 1.

7.

The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation.

Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, Chan DN, Conway S, Orkin SH, Yoder MC, Mikkola HK.

Cell Stem Cell. 2008 Mar 6;2(3):252-63. doi: 10.1016/j.stem.2008.01.001.

8.

Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord.

Galtrey CM, Kwok JC, Carulli D, Rhodes KE, Fawcett JW.

Eur J Neurosci. 2008 Mar;27(6):1373-90. doi: 10.1111/j.1460-9568.2008.06108.x.

PMID:
18364019
9.

How does chondroitinase promote functional recovery in the damaged CNS?

Crespo D, Asher RA, Lin R, Rhodes KE, Fawcett JW.

Exp Neurol. 2007 Aug;206(2):159-71. Epub 2007 May 8. Review.

PMID:
17572406
10.

Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells.

Schenke-Layland K, Angelis E, Rhodes KE, Heydarkhan-Hagvall S, Mikkola HK, Maclellan WR.

Stem Cells. 2007 Jun;25(6):1529-38. Epub 2007 Mar 15.

11.
12.

ABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are associated with toxicity in metastatic colorectal cancer patients treated with first-line irinotecan.

Rhodes KE, Zhang W, Yang D, Press OA, Gordon M, Vallböhmer D, Schultheis AM, Lurje G, Ladner RD, Fazzone W, Iqbal S, Lenz HJ.

Drug Metab Lett. 2007 Jan;1(1):23-30.

PMID:
19356014
13.

Molecular determinants of irinotecan efficacy.

Vallböhmer D, Iqbal S, Yang DY, Rhodes KE, Zhang W, Gordon M, Fazzone W, Schultheis AM, Sherrod AE, Danenberg KD, Lenz HJ.

Int J Cancer. 2006 Nov 15;119(10):2435-42.

14.

The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines.

Rhodes KE, Raivich G, Fawcett JW.

Neuroscience. 2006 Jun 19;140(1):87-100. Epub 2006 Apr 21.

PMID:
16631314
15.

A novel role for Sema3A in neuroprotection from injury mediated by activated microglia.

Majed HH, Chandran S, Niclou SP, Nicholas RS, Wilkins A, Wing MG, Rhodes KE, Spillantini MG, Compston A.

J Neurosci. 2006 Feb 8;26(6):1730-8.

16.

Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components.

Carulli D, Rhodes KE, Brown DJ, Bonnert TP, Pollack SJ, Oliver K, Strata P, Fawcett JW.

J Comp Neurol. 2006 Feb 1;494(4):559-77.

PMID:
16374793
17.

Molecular determinants of cetuximab efficacy.

Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun J, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ.

J Clin Oncol. 2005 May 20;23(15):3536-44.

PMID:
15908664
18.

The responses of oligodendrocyte precursor cells, astrocytes and microglia to a cortical stab injury, in the brain.

Hampton DW, Rhodes KE, Zhao C, Franklin RJ, Fawcett JW.

Neuroscience. 2004;127(4):813-20.

PMID:
15312894
19.

Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia.

Dobbertin A, Rhodes KE, Garwood J, Properzi F, Heck N, Rogers JH, Fawcett JW, Faissner A.

Mol Cell Neurosci. 2003 Dec;24(4):951-71.

PMID:
14697661
20.

Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Rhodes KE, Fawcett JW.

J Anat. 2004 Jan;204(1):33-48. Review.

21.
22.
23.

Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC.

Moon LD, Asher RA, Rhodes KE, Fawcett JW.

Nat Neurosci. 2001 May;4(5):465-6. No abstract available.

PMID:
11319553
24.

Supplemental Content

Loading ...
Support Center